The authors have requested to retract this article, since in the lately repeated and further experiments they found MAP3K5 maybe not the true target gene of miR-BART22.
. 2017 Sep 8;8(16):3130. doi: 10.7150/jca.22507
Retraction: The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma
Ruichao Chen
1,*, Minfeng Zhang
1,*, Qiulian Li
1,5,*, Hanzhen Xiong
1, Shaoyan Liu
1, Weiyi Fang
3, Qianbing Zhang
3, Zhen Liu
1,2,✉, Xuehu Xu
4,✉, Qingping Jiang
1,✉
Ruichao Chen
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
Find articles by Ruichao Chen
Minfeng Zhang
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
Find articles by Minfeng Zhang
Qiulian Li
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
5Department of obstetrics and gynecology, First affiliated
hospital, Gannan medical university, Gannan,341000, PR, China.
Find articles by Qiulian Li
Hanzhen Xiong
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
Find articles by Hanzhen Xiong
Shaoyan Liu
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
Find articles by Shaoyan Liu
Weiyi Fang
3Cancer Research Institute, Southern Medical University,
Guangzhou, 510515, PR China;
Find articles by Weiyi Fang
Qianbing Zhang
3Cancer Research Institute, Southern Medical University,
Guangzhou, 510515, PR China;
Find articles by Qianbing Zhang
Zhen Liu
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
2Department of Pathology, Basic school, Guangzhou Medical
University, Guangzhou,510000, PR China;
Find articles by Zhen Liu
Xuehu Xu
4Gastrointestinal Department, Third Affiliated Hospital,
Guangzhou Medical University, Guangzhou, 510150, PR, China;
Find articles by Xuehu Xu
Qingping Jiang
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
Find articles by Qingping Jiang
1Department of Pathology, Third Affiliated Hospital, Guangzhou
Medical University, Guangzhou, 510150, PR, China;
2Department of Pathology, Basic school, Guangzhou Medical
University, Guangzhou,510000, PR China;
3Cancer Research Institute, Southern Medical University,
Guangzhou, 510515, PR China;
4Gastrointestinal Department, Third Affiliated Hospital,
Guangzhou Medical University, Guangzhou, 510150, PR, China;
5Department of obstetrics and gynecology, First affiliated
hospital, Gannan medical university, Gannan,341000, PR, China.
✉
✉ Corresponding authors: Qingping Jiang:jiangqingping@gzhmu.edu.cn; Xuehu Xu: maxtiger@126.com; Zhen Liu:narcissus_jane@163.com.
* These authors contributed equally to this work.
Collection date 2017.
© Ivyspring International Publisher
This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
PMCID: PMC5665028 PMID: 29158784
This retracts the article "The Epstein-Barr Virus-encoded miR-BART22 targets MAP3K5 to promote host cell proliferative and invasive abilities in nasopharyngeal carcinoma" on page 305.